Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01RQV
|
|||
| Former ID |
DIB005620
|
|||
| Drug Name |
Eculizumab
|
|||
| Synonyms |
Eculizumab (intravitreal, AMD); Eculizumab (intravitreal, AMD), Alexion; Eculizumab (intravitreal, age-related macular degeneration), Alexion
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-9: 362.5] | Approved | [1], [2] | |
| Company |
Alexion Pharmaceuticals Inc
|
|||
| ADReCS Drug ID | BADD_D00742 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6884). | |||
| REF 2 | ClinicalTrials.gov (NCT02013037) The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.